CoreWeave (CRWV) Form 144: 250,000 Shares Proposed Sale ($23.4M)

Notice of proposed sale under Rule 144 for CoreWeave, Inc. (CRWV): The filing reports a planned sale of 250,000 common shares through Morgan Stanley Smith Barney LLC with an approximate aggregate market value of $23,387,500.

Rhea-AI Filing Summary

Notice of proposed sale under Rule 144 for CoreWeave, Inc. (CRWV): The filing reports a planned sale of 250,000 common shares through Morgan Stanley Smith Barney LLC with an approximate aggregate market value of $23,387,500. The sale is slated for 09/09/2025 on NASDAQ and the reported number of shares outstanding is 370,470,348.

The shares were acquired as founders shares on 11/13/2017. The filing also lists multiple Rule 10b5-1 sales by Brannin McBee and the Brannin J. McBee 2022 IRR Trust during Aug–Sep 2025, showing recent insider dispositions and the use of trading plans.

Positive

• Compliance with disclosure rules: The filing provides the required Rule 144 information and includes the representational statement regarding material nonpublic information.
• Use of 10b5-1 plans: Multiple entries show sales executed under 10b5-1 arrangements, indicating pre-arranged, procedurally compliant insider selling.

Negative

• Significant insider sell volume in recent months: The filing and prior entries show repeated sales in Aug–Sep 2025 (multiple 250,000 and 375,000 share transactions) which may concern some investors.
• Large single-sale value: The proposed 250,000-share sale has an aggregate market value of $23,387,500, a sizable insider liquidity event relative to an individual transaction.

Insights

Securities Analyst

TL;DR: Routine Rule 144 notice showing insider-originated sale and recent 10b5-1 transactions; appears to be compliance-driven, not an operational disclosure.

The filing documents a proposed sale of 250,000 common shares (aggregate value ~$23.4M) to be executed on 09/09/2025 via Morgan Stanley. The shares were originally acquired as founders shares on 11/13/2017. The schedule of sales in Aug–Sep 2025 shows multiple 10b5-1 plan executions by Brannin McBee and an associated trust, indicating systematic insider selling. From a market-impact perspective, this is a disclosure of insider liquidity rather than new company operational information.

Corporate Governance Expert

TL;DR: The filing documents compliance with Rule 144 and signals use of 10b5-1 plans; governance process appears followed.

The notice includes the representational statement required by the form about absence of undisclosed material information and cites adoption/execution of trading plans. The seller states acquisition as founders shares, and recent entries list multiple 10b5-1 sales by the named insider and trust in Aug–Sep 2025. This filing primarily documents executed governance and disclosure procedures for insider sales.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filed for CoreWeave (CRWV) disclose?

The Form 144 discloses a proposed sale of 250,000 common shares via Morgan Stanley on 09/09/2025 with an aggregate market value of $23,387,500 and total shares outstanding of 370,470,348.

When were the shares being sold originally acquired?

The shares were acquired as founders shares on 11/13/2017 according to the filing.

Who is executing the sales recorded in the filing?

Sales are recorded for Brannin McBee and the Brannin J. McBee 2022 IRR Trust, including multiple 10b5-1 sales in Aug–Sep 2025.

Through which broker will the proposed sale be executed?

The proposed sale lists Morgan Stanley Smith Barney LLC (Executive Financial Services, New York) as the broker.

What trading mechanism is referenced for recent insider sales?

The filing references multiple 10b5-1 sales, indicating the use of pre-arranged trading plans for the insider dispositions.

Does the filing state whether undisclosed material information exists?

By signing, the person for whose account the securities are to be sold represents they do not know any material adverse information not publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 09/09/2025 - 04:28 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002058103
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CoreWeave, Inc.
SEC File Number	001-42563
Address of Issuer	290 W Mt. Pleasant Ave. Suite 4100 Livingston NEW JERSEY 07039
Phone	9732709737
Name of Person for Whose Account the Securities are To Be Sold	BRANNIN MCBEE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	250000	23387500.00	370470348	09/09/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/13/2017	Founders Shares	Issuer			250000	11/13/2017	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/02/2025	250000	23292325.00
10b5-1 Sales for BRANNIN J. MCBEE 2022 IRR TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/02/2025	375000	34938487.50
10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/26/2025	250000	22996925.00
10b5-1 Sales for BRANNIN J. MCBEE 2022 IRR TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/26/2025	375000	34495387.50
10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/19/2025	250000	22926475.00
10b5-1 Sales for BRANNIN J. MCBEE 2022 IRR TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/19/2025	375000	34389712.50

144: Remarks and Signature

Remarks
Date of Notice	09/09/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/20/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Brannin McBee
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)